Sem Sælands vei 3
The Norwegian society for pharmacoepidemiology, in collaboration with the PharmaTox strategic research initiative, welcomes members to the yearly meeting the 19th of April. New members are also welcome!
In the latest Norsk Farmaceutisk Tidsskrift we can read about pharmacy student Tor Halvor Johansen who got a job in Store norske leksikon after a school exercise.
The Norwegian PhD School of Pharmacy invites to a series of seminars and guest lectures on pharmacoeconomics.
New article in Titan about the collaboration between PharmaTox researchers and Smartfish entrepreneurs, on verifying the advantages of nutrition drinks.
NFIF invites to a seminar with the theme "Pharmacoeconomics as a tool for rational reimbursement decision making" on the 1st of February.
The 3rd Nordic PhD meeting in Social and Clinical Pharmacy will be held on the 8th-10th of February 2017 in Copenhagen. The theme of the meeting is "Reaching your goals - Approaching thesis writing, oral defense and theory".
This semester, 13 new Master's students start at PharmaSafe. The topics they are working on include drug safety during pregnancy, drug information and use of ADHD medication.
Read more here.
PharmaSafe PhD students attended a course on "Advanced pharmacoepidemiology" in Stockholm November 15th-16th, and the 9th NorPEN meeting November 16th-18th.
Several PharmaSafe researchers presented their work at Farmasidagene November 3rd-4th.
Professor Hedvig Nordeng is awarded Pharmacist of the year prize for 2016 for her effort to put the drug use in children, pregnant and nursing on the map with her research.
Professor Hedvig Nordeng, one of the initiators of a study of Metoklopramid usage during pregnancy, interviews in Dagens Medisin about the study results.
Master student Laila Ichoutene from Pharmasafe research group comments on her thesis in Dagens Medisin.
This year, Anne Gerd Granås had the pleasure of welcoming more than 600 participants from 40 different countries to the annual Symposium of the European Society of Clinical Pharmacy (ESCP) in Oslo 5th -7th October. A record breaking 110 participants from Norway took part, many for the first time at international conference. The three days were filled with lectures, 19 different workshops, posters and oral presentations.
Angela Lupattelli comments in Reuters Health News on JAMA patient page publication regarding remedies for morning sickness
PharmaSafe logo files can be downloaded here.
Migraine is highly prevalent among women of fertile age. The main objectives of this study were to describe the prevalence and patterns of use of antimigraine medications during pregnancy and breastfeeding and to identify maternal and migraine-related factors associated with medication use during pregnancy.
New article in Titan: Scientists have developed new tools and data sets that provide accurate information on how pregnant women can use medicine safely.
New article by PharmaTox postdoc Mollie Wood published on BMJ open.
Short term use of paracetamol in pregnancy seems safe, but long-term use was associated with delayed psychomotor development in the latest MoBa study.
Several PharmaSafe researchers attended the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 25-28 in Dublin which was organized by the International Society of PharmacoEpidemiology (ISPE).
We welcome Lene Sundbakk!
Read about Lene's background.
A new study shows Paracetamol use during pregnancy increases the risk of hyperactivity in children. Professor Hedvig Nordeng confirms that such results have been seen in three previous studies.